Results

Total Results: 1,187 records

Showing results for "week".

401. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - Only a fraction of patients respond within a week of administration of many of the medications available … depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4- week

402. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/01_-arthritis_potential_high_impact_june_2012.pdf
     January 01, 2012 - compared with similar patients concurrently treated with hyaluronic acid injection (n=21) three times, 1 week … twice daily, adalimumab (Humira ® ; Abbott Laboratories, Abbott Park, IL) 40 mg injected every other week

403. Obesity-Child Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/obesity-child_executive.pdf
     March 31, 2010 - families and patients on behavioral goals, and overall practice and provider management over a 78-week … but it showed significant improvements in sedentary behaviors for both sexes and in active days per week

404. Medical Therapies for Children With Autism Spectrum Disorder—An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-executive-170505.pdf
     May 01, 2017 - placebo in 3 RCTs with 6-8 week treatment phases; improvement maintained in 2 RCTs with 6 months of … , no differences in time to relapse of symptoms between aripiprazole and placebo groups in one 16 week … RCT and continued improvements in ABC in one 52-week open label continuation with no control arm

405. Disposition of Comments Report for Multigene Panels in Prostate Cancer Risk Assessment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_disposition-comments.pdf
     July 03, 2012 - effectiveness research review is posted to the EHC Program Web site in draft form for public comment for a 4-week

406. Interventions for Breathlessness in Patients With Advanced Cancer: Evidence Summary (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dyspnea-advanced-cancer-summary-1.pdf
     November 01, 2020 - Interventions for Breathlessness in Patients With Advanced Cancer: Evidence Summary Comparative Effectiveness Review Number 232 Interventions for Breathlessness in Patients With Advanced Cancer Evidence Summary Main Points For patients with advanced cancer: • Airflow interventions (fans) were …

407. THIS IS OUR TEACHER! (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_media_wilkes.ppt
     April 01, 2006 - Narrow Focus on a few journals Journalists have been criticized for having a limited focus; Each week

408. Mindfulness-Based Interventions for Wellbeing and Mental Health in Children and Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amendment.pdf
     February 05, 2025 - Mindfulness-Based Interventions for Wellbeing and Mental Health in Children and Adolescents: A Systematic Review 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Mindfulness-Based Interventions for Wellbeing and Mental Health in Children and Adolescents: A …

409. Mindfulness-Based Interventions for Wellbeing and Mental Health in Children and Adolescents: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ped-mindfulness-protocol-amended.pdf
     September 25, 2024 - Mindfulness-Based Interventions for Wellbeing and Mental Health in Children and Adolescents: A Systematic Review Evidence-based Practice Center Systematic Review Protocol Project Title: Mindfulness-Based Interventions for Wellbeing and Mental Health in Children and Adolescents: A Systematic Review Initial Public…

410. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
     July 06, 2015 - Search Strategy Database: Ovid MEDLINE(R) and Ovid OLDMEDLINE(R) <1946 to June Week 4 2015>, Ovid

411. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-2007_executive.pdf
     January 01, 2007 - The number needed to treat (NNT) to gain one additional responder at week 8 with escitalopram was 14

412. Ankyloglossia Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ankyloglossia_executive.pdf
     May 01, 2015 - 1 Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie Executive Summary Introduction Ankyloglossia is a congenital condition characterized by an abnormally short, thickened, or tight lingual frenulum, or an anterior attachment of the lingual frenulum, that restricts mobility of the tongue.1…

413. S3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s3.pdf
     October 01, 2007 - EDITORIAL The Comparative Effectiveness and Safety Emerging Methods Symposium A Tribute to Harry A. Guess: Father and Consummate Leader of Pharmacoepidemiology David J. Ballard, MD, PhD This symposium and supplement dedicated to Harry Guess provides us with an opportunity to celebrate Harry’s life and his myriad co…

414. Bladder-Cancer-Non-Muscle-Invasive Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_executive.pdf
     October 01, 2015 - 1 Comparative Effectiveness Review Number 153 Emerging Approaches to Diagnosis and Treatment of Non–Muscle-Invasive Bladder Cancer Executive Summary Background Bladder cancer is the 4th most commonly diagnosed cancer in men and the 10th most commonly diagnosed cancer in women in the United States.1 The Ameri…

415. Rapid Response_The Association Between Outcomes and Dental Services in Persons With Autoimmune Disease Treated With Biologics and Other Immunosuppressants: A Rapid Response Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/autoimmune-disease-rapid-research.pdf
     November 01, 2024 - mean difference; SR: systematic review; TNF: tumor necrosis factor; VAS: visual analog scale; wk: week … SLE: systemic lupus erythematosus: SRP: scaling and root planing; TNF: tumor necrosis factor; wk: week … erythematosus disease activity index; SRP: scaling and root planing; VAS: visual analog scale; wk: week … Yarkac 2019 was the only RCT that measured IL-2, IL- 6, and slgA levels in saliva samples.34 At the 8-week … necrosis factor USPSTF United States Preventive Services Task Force VAS Visual analogue scale wk Week

416. Disposition of Comments_CER 241: Physical Activity and the Health of Wheelchair Users: A Systematic Review in Multiple Sclerosis, Cerebral Palsy, and Spinal Cord Injury (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-241-wheelchair-users-disposition-comments.pdf
     October 18, 2022 - draft report is posted to the EHC Program website or AHRQ website for public comment for a 3- to 4-week

417. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - drinking and alcohol-related emergency department readmission among at-risk patients completing a 12-week … Across a 12-week study, patients randomly received no text messaging intervention (control group),

418. #05 DEPRESSION (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
     October 01, 2014 - Only a fraction of treated patients respond within a week of starting any of the many medications available … depressive symptoms to a single intravenous infusion of ketamine vs add-on riluzole: results from a 4- week

419. Tinnitus Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tinnitus_executive.pdf
     August 01, 2013 - significant effects on multiple outcomes was sertraline, which was evaluated against placebo in a 16-week

420. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
     January 01, 2012 - with similar patients concurrently treated with hyaluronic acid injection (n=21) three times, with 1 week … were given tofacitinib 5 or 10 mg twice daily, adalimumab (Humira ® ) 40 mg injected every other week